ATI-2307 (T-2307), an aromatic amidine compound, represents a novel class of mitochondrial respiratory chain inhibitors (Yamashita et al., 2019)
Chronic sleep deprivation or poor sleep quality impairs these restorative processes, potentially reducing glutathione synthesis capacity and increasing oxidative stress through various mechanisms including increased inflammatory signaling, impaired glucose metabolism, disrupted circadian rhythms affecting antioxidant enzyme expression, and increased psychological stress responses
In patients suffering from ME/CFS and Long COVID, relentless oxidative damage physically alters the delicate structure of the mitochondria
Currently, no animal studies have conducted BPC-157 cancer risk evaluation
At present, effective clinical treatments for stroke are elusive, partly due to the challenges posed by the BBB, which hinders the delivery of medications to the damaged brain regions[51]